India's economic engine is revving up, but navigating the global headwinds requires sharp strategy. The rupee's recent volatility against the dollar underscores the complexities facing Indian businesses, impacting everything from import-export trade to domestic inflation. This week alone, we've seen significant shifts in the IT sector, with major players announcing restructuring and a renewed focus on AI-driven solutions. Meanwhile, the burgeoning startup ecosystem continues to attract substantial funding, despite a cautious global investor sentiment. The government's recent policy announcements on infrastructure development and digitalization are poised to further shape the business landscape, creating both opportunities and challenges for entrepreneurs and established corporations alike. Understanding these market dynamics is crucial for success in today's rapidly evolving Indian economy. Stay informed with Abtak.com for the latest insights and analysis on key sectors including finance, manufacturing, and technology – empowering your business decisions in a dynamic market. Explore the complete business news section now to stay ahead of the curve.
Aug 1 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab beat Wall Street estimates for second-quarter revenue and profit on Friday helped by robust demand for its blockbuster eczema treatment, Dupixent, sending its shares up nearly 3% in premarket trading. Investors have set a high bar for Regeneron and French partner Sanofi's (SASY.PA), opens new tab Dupixent, one of the U.S. drugmaker's growth drivers, especially after it received approval to treat a common lung condition called ch
New Delhi [India], July 16 (ANI): The Indian government expressed regret on Tuesday over the reported demolition of the ancestral property of celebrated filmmaker and writer Satyajit Ray in Mymensingh, Bangladesh and expressed its willingness to extend cooperation in its restoration. "We note with profound regret that the ancestral property of noted filmmaker and litterateur Satyajit Ray in Mymensingh, Bangladesh, belonging to his grandfather and eminent litterateur, Upendra Kishor Ray Chowdhury, is being demolished," the Ministry of External Affairs said. Also Read | India Urges Bangladesh ...Read More >
Mumbai, July 3 (SocialNews.XYZ) Maharashtra Chief Minister Devendra Fadnavis on Thursday said that hydro ganja is proving to be a big challenge for the government, and since it has been legalised in Thailand and America, cases of it being sent via parcel are increasing. He told the state council that the state has written to reduce the commercial quantity of drugs in the rules, which can lead to longer jail terms for the peddlers. "Hydro ganja is proving to be a challenge. Thailand and the US have made it legal. So, hydro ganja is being pushed into the country through courier services and ot ...Read More >
European stocks rose on Friday, heading for small weekly gains, as investors focused on corporate earnings to assess the impact of US tariffs on businesses. The STOXX 600 index climbed 0.3% to 548.84 points, set for its second weekly gain. Other major indexes, including Germany's DAX, France's CAC40, and Britain's FTSE 100, also saw modest increases. Swedish defense company Saab jumped 12.7%, leading the STOXX 600, after reporting better-than-expected second-quarter earnings and raising its sal ...Read More >
MUMBAI, Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the world's most populous nation, a senior executive said on Thursday. "I do think there is promise for products like that (orforpligron) in India, if it does get approved," Winselow Tucker, Lilly India's president said at an event in Mumbai. Tucker, however, did not indicate when Lilly plans to launch the drug. The drugmaker ha ...Read More >
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular weight-loss drug Wegovy over fears of falling behind rival Eli Lilly in the potentially huge market, two sources familiar with the plans told Reuters. Officials at the Danish drugmaker have said Wegovy might be introduced in India in 2026 once regulatory approvals are in hand and there is sufficient supply. More recently, Novo's India team proposed moving the launch to next year, around the same time Lilly is expected to introduce its weight-loss drug Mounjaro. In a clo ...Read More >
India Diabetes Market: By Type; By Treatment Type; By Doses Form; Route of Administration; By End User; By Distribution Channel; Supplier Landscape; 2025-2034 The India diabetes market attained a value of approximately INR 316.00 Billion in 2024. The market is projected to grow at a compound annual growth rate (CAGR) of 16.00% during the forecast period of 2025-2034, reaching an estimated value of around INR 1394.01 Billion by 2034. The rising prevalence of diabetes, driven by sedentary lifestyles, changing dietary habits, and increasing obesity rates, is contributing significantly to the mar ...Read More >
July 17 (Reuters) - The U.S. Food and Drug Administration has authorized the sale of Juul's e-cigarette device and refill cartridges in tobacco and menthol flavors, a source familiar with the matter told Reuters on Thursday. The decision follows wide expectation within the industry that the Trump Administration would ease regulatory hurdles for launching new vapes and other smoking alternatives. Some companies have seen FDA applications for new nicotine products languish for years or, like Juul ...Read More >
Mumbai, Oct 31 (SocialNews.XYZ) Actress Deepika Padukone, who has been a strong advocate for mental health awareness, reacted to cricketer Jemimah Rodrigues' recent revelation about battling anxiety. The 'Om Shanti Om' actress, known for openly sharing her own struggles with depression in the past, praised Jemimah for her honesty and courage in speaking up, highlighting the importance of conversations around mental well-being in sports and beyond. Taking to her Instagram Stories, Deepika Padukone reshared a video of cricketer Jemimah Rodrigues, in which the athlete opened up about her struggl ...Read More >
New Delhi, Sep 30 (PTI) India's drug regulator Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic (semaglutide injection) manufactured by Danish pharma company Novo Nordisk for use in adults with type-2 diabetes. According to sources, Ozempic, the once-a-week injection, will be available only on a doctor's prescription. "Semaglutide Injection (Ozempic@) is indicated for the treatment of adults with Insufficiently Controlled Type 2 Diabetes Mellitus as an adjunct to Diet and Exercise," the approval by CDSCO said on September 26. The US Food and Drug Administration had a ...Read More >
April 1 (Reuters) - U.S. stock futures advanced on Wednesday, after the indexes saw their biggest one-day gains in nearly a year in the previous session, following President Donald Trump's comments that suggested a swift end to the Middle East conflict. Trump and Secretary of State Marco Rubio said on Tuesday that the end of the Iran war could be near, signaling potential for both direct talks with Iranian leadership and a winding down of the conflict without a deal. Trump is scheduled to addres ...Read More >
AstraZeneca, Pfizer, and Eli Lilly, major players in the pharmaceutical and vaccine sectors, are drawing renewed attention as investors consider the shifting political landscape. AstraZeneca's cancer treatments, including Imfinzi and Calquence, are driving strong revenue growth, while the company plans to launch up to 24 new products by 2030. Eli Lilly, bolstered by its diabetes treatments like Mounjaro and Zepbound, has seen impressive stock gains, despite recent guidance cuts. Pfizer, although facing volatility, is a solid value investment with strong long-term potential. These companies' ro ...Read More >
New Delhi, Jun 30 (PTI) Alembic Pharmaceuticals on Monday said it has received the final approval from the US health regulator for its generic Doxorubicin Hydrochloride Liposome injection in different types of cancer. The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) is for Doxorubicin Hydrochloride Liposome injection of strengths 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials, Alembic Pharmaceuticals said in a statement. The approved ANDA is therapeutically equivalent to the reference-listed drug product (RLD), Doxil ...Read More >
(Reuters) -An Australian court on Wednesday stopped U.S. drugmaker Cosette from abandoning its A$672 million ($437.6 million) takeover of Mayne Pharma, which now awaits clearance from the Foreign Investment Review Board (FIRB). The ASX-listed pharmaceutical company said on Thursday it would take all steps within its scope to implement the deal. Shares in Mayne Pharma jumped as much as 14.8% to A$6.5 at open in Sydney, but were still trading way below the A$7.40 apiece that Cosette had offered. ...Read More >
New Delhi: Industry leaders welcomed the recently announced GST reforms, which reduce the number of tax slabs, stating that it will make tax compliance easier while also directly benefiting consumers through lower prices. Jharkhand Chamber of Commerce Joint Secretary Navjot Alang Rubal said that the reduction of the number of slabs from four to two under the new GST structure is a highly positive step. According to Rubal, this reform will greatly benefit the middle and lower-income groups as the tax reductions on essential items of daily use will bring a noticeable drop in prices. He furthe ...Read More >
(Reuters) -Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion. The collaborations aim to increase the availability of Lilly's key drugs, including those for obesity, diabetes, Alzheimer's, cancer and autoimmune conditions, the company said. "We are making significant investments to increase manufactur ...Read More >
New Delhi [India], October 31 (ANI): The U.S. Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar medicines, lower-cost "generic" alternatives to biologic drugs used to treat serious and chronic diseases. In a new draft guidance, the FDA has proposed major updates aimed at simplifying biosimilarity studies and reducing unnecessary clinical testing. The agency also launched a separate initiative to make it easier for biosimilars to be developed as interchangeable with brand-name biologics, allowing patients and pharmacists to ch ...Read More >
MUMBAI: RBI on Friday issued revised norms for loans backed by gold and silver, aimed at widening credit access for small borrowers and standardising regulations across banks and NBFCs. The new rules will come into force from April 1, 2026.Under the revised framework, loan-to-value (LTV) ratio for smaller consumption loans has been increased. Borrowers can now avail loans up to Rs 2.5 lakh with an LTV of 85%, up from 75%. For loans above Rs 2.5 lakh and up to Rs 5 lakh, the LTV is capped at 80%, while loans exceeding Rs 5 lakh will continue to have a 75% ceiling. For bullet repayment loans, le ...Read More >
New Delhi [India], August 14 (ANI): The credit-to-deposit ratio in Indian banks has stayed below 80 per cent as credit offtake in the country continues to lag, according to a report by CareEdge Ratings. The report highlighted that while both credit offtake and deposit growth have increased sequentially, they remain significantly lower than the levels seen last year. Deposits continued to outpace credit offtake in the current fortnight, leading to a narrowing of the credit-deposit gap. It stated Credit to Deposit Ratio Remains Below 80 per cent as Credit Offtake Lags. The report data pointed ...Read More >
March 31 (Reuters) - Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off competition from cheaper generics made by local drugmakers. India's market for diabetes and weight-loss drugs is set for a shake-up after the Danish drugmaker's patent on semaglutide, the active component in Ozempic and Wegovy, expired on March 20. At least half a dozen Indian drugmakers, including Dr Reddy's, Zydus an ...Read More >